Health policy analyst Paul Keckley, PhD, offers three key lessons other healthcare organizations best heed from the Mylan controversy, according to Hospitals & Health Networks.
Here are three key points:
1. Healthcare doesn’t understand the meaning of “secrets.” From patients who are quick to discuss their experiences to employees who don’t hesitate to expand on their company cultures, the inner workings of just about anything will eventually come to light in this industry.
2. Company boards run the show, and can just as easily destroy a company as they can make a company. Therefore, boards must remember to guide a company in the direction balanced by “profit and social purpose,” and offer a transparent view of pricing strategies to both those inside and outside the company.
3. A CEO is the face of a company, especially in times of crisis, and must present an even-tempered, trustworthy demeanor. If they fail to do so, the company’s longevity and reputation may very well be decided in a moment.
More articles on practice management:
Public supports limiting shift hours for first-year residents — 4 things to know
ASC-based outpatient, hospital-based inpatient total shoulder arthroplasty prove equally safe: 5 study insights
FDA holds 2-day public hearing on stem cell regulation: 5 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
